Eptinezumab (Anti-CALCA / CGRP)
Eptinezumab (Anti-CALCA / CGRP) (A2790-GRP)
Products
Description
Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2790 |
| Target | CGRP Receptor |